We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$270M
AUM Growth
+$16.6M
Cap. Flow
+$5.68M
Cap. Flow %
2.1%
Top 10 Hldgs %
45.2%
Holding
54
New
4
Increased
12
Reduced
36
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.68M
2
AMGN icon
Amgen
AMGN
+$2.39M
3
PKG icon
Packaging Corp of America
PKG
+$1.97M
4
HUBB icon
Hubbell
HUBB
+$1.64M
5
MSFT icon
Microsoft
MSFT
+$510K

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$730K
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$502K
3
PG icon
Procter & Gamble
PG
+$419K
4
MCHP icon
Microchip Technology
MCHP
+$370K
5
HON icon
Honeywell
HON
+$292K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.52%
2 Healthcare 13.85%
3 Financials 13.75%
4 Energy 12.85%
5 Technology 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWF icon
51
iShares Russell 1000 Growth ETF
IWF
$121B
$434K 0.16%
15,248
+396
+3% +$11K
VYM icon
52
Vanguard High Dividend Yield ETF
VYM
$80.9B
$306K 0.11%
3,939
+885
+29% +$68.3K
MDY icon
53
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$278K 0.1%
890
– –
CAH icon
54
Cardinal Health
CAH
$53.9B
$257K 0.1%
3,148
– –
1 2
3

Similar funds

SEP
Signature Equity Partners Columbus, Ohio $186M AUM
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BGA
Battery Global Advisors Boston, Massachusetts $186M AUM 15.74% 1-Year Est. Return
OBC
Oakum Bay Capital Westport, Connecticut $187M AUM
LPCM
Lynwood Price Capital Management Austin, Texas $186M AUM 5.63% 1-Year Est. Return
HC
Hurley Capital New York $187M AUM 23.24% 1-Year Est. Return
AC
AMANSA Capital Raffles City Tower, Singapore $187M AUM 38.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $187M AUM 18.9% 1-Year Est. Return

Brookmont Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Brookmont Capital Management held 54 positions worth $270M, up 6.5% from $254M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Brookmont Capital Management's Q1 2017 filing shows 4 new, 12 increased and 36 reduced positions. Its largest new stake was Gilead Sciences: 38,081 shares worth $2.59M. The largest sale was Abbott, an estimated $730K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Brookmont Capital Management's largest Q1 2017 buy was Gilead Sciences: 38,081 shares worth $2.59M.
  • Brookmont Capital Management added most to Amgen in Q1 2017, an estimated $2.39M increase.
  • Brookmont Capital Management's biggest Q1 2017 reduction was Abbott, cutting an estimated $730K.
  • Brookmont Capital Management's ten largest holdings make up 45% of its $270M portfolio in Q1 2017.
  • Brookmont Capital Management opened 4 new positions and closed 0 in Q1 2017.
  • Brookmont Capital Management's portfolio value rose 6.5% quarter-over-quarter to $270M.

Based on Brookmont Capital Management's 13F filing for Q1 2017, filed 15 May 2017.